Pulished Date October, 2018
ID: 7151
Share on
Share on

Middle East And Africa Microbiology Testing/Clinical Microbiology Market By Microbiology Application (Pharmaceutical, Clinical, Manufacturing, Energy), By Clinical Application (Respiratory Diseases, STD, UTI), By Product (instruments, Analysers, Consumables) And By Region - Middle-East And Africa Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018-2023)

Pulished: October, 2018
ID: 7151
Pages: 145

Middle East and Africa Microbiology Testing/Clinical Microbiology Market was worth USD 0.51 million in 2018 and is projected to be growing at a CAGR of 9.39%, to touch USD 0.80 billion by 2023. Medical microbiology is a branch of medical science concerned with the prevention, diagnosis and treatment of infectious diseases. In addition, this field of science studies various clinical applications of microbes for the improvement of health.

Medical microbiologists often serve as consultants for physicians, providing identification of pathogens and proposing treatment options. Other tasks may include the identification of potential health hazards to the community or observing the evolution of potentially virulent or resistant strains of microbes, educating the community and assisting in the design of health practices.

The growth of the Middle East and Africa Microbiology Testing/Clinical Microbiology Market is majorly riding on the technological advancements, increasing incidence of infectious diseases and rising outburst of epidemics; growing healthcare spending across the world; and growing funding, research grants, and public-private investments. Furthermore, refining healthcare infrastructure across the developing markets and growing market demand for advanced molecular diagnostic products provide opportunities for players in the clinical microbiology market. Operative barriers for diagnostic test usage and bundled sales by market giants across major markets are the key challenge restraining the growth of the Middle East and Africa clinical microbiology market.

The Middle East and Africa Microbiology Testing/Clinical Microbiology Market is segmented on the basis of Application, Clinical Application, Product, and Geography. Based on Product, the Microbiology Testing/Clinical Microbiology market is divided into Pharmaceutical, Clinical, Manufacturing and Energy. The Clinical Application or Disease Area segment consists of Respiratory Diseases, STD and UTI. The Microbiology Testing/Clinical Microbiology Product segment is categorised into Instruments, Analyzers, and Consumables.

The market has been geographically segmented into Middle East and Africa. Currently, the Middle-East and Africa market faces slow growth due low awareness about these techniques among the populace which is further amplified by low infrastructural investments in this sector. However, propositions by key companies to expand into untapped markets coupled with govermnet plans for increase investments is expected to augment market growth in the Middle-East and Africa.

The key players in the Middle-East and Africa Microbiology Testing/Clinical Microbiology Market are Danaher Corporation (U.S.), Becton, Dickinson and Company (U.S.), Cepheid (U.S.) Abbott Laboratories Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), F. Hoffman-La Roche Ltd. (Switzerland), Alere Inc. (U.S.), Bruker Corporation (U.S.), and Hologic, Inc. (U.S.), among others.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Product                        

                                5.1.1 Introduction           

                                5.1.2 Instruments           

                                                5.1.2.1 Laboratory Instruments

                                                5.1.2.2 Microbiology Analyzers

                                5.1.3 Reagents 

                                5.1.5  Y-o-Y Growth Analysis, By Product              

                                5.1.6  Market Attractiveness Analysis, By Product            

                                5.1.7  Market Share Analysis, By Product              

                5.2 Application                 

                                5.2.1 Introduction           

                                5.2.2 Pharmaceutical     

                                5.2.3 Clinical       

                                5.2.4 Food Testing          

                                5.2.5 Energy      

                                5.2.6 Chemical and Material Manufacturing        

                                5.2.7 Environmental       

                                5.2.8 Y-o-Y Growth Analysis, By Application         

                                5.2.9 Market Attractiveness Analysis, By Application       

                                5.2.10 Market Share Analysis, By Application      

                5.3 Disease Area                              

                                5.3.1 Introduction           

                                5.3.2 Respiratory Disseases        

                                5.3.3 Bloodstream Infections     

                                5.3.4 Gastrointestinal Diseases 

                                5.3.5 Sexually Transmitted Diseases       

                                5.3.6 Urinary Tract Infections     

                                5.3.7 Periodontal Diseases          

                                5.3.8 Others      

                                5.3.9 Y-o-Y Growth Analysis, By Disease Area     

                                5.3.10  Market Attractiveness Analysis, By Disease Area

                                5.3.11  Market Share Analysis, By Disease Area 

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Product

                                                6.1.3.3 By Application

                                                6.1.3.4 By Disease Area

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Product

                                                6.1.4.3 By Application

                                                6.1.4.4 By Disease Area

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Product

                                                6.1.5.3 By Application

                                                6.1.5.4 By Disease Area

                6.2 Middle-East                                

                6.3 Africa                            

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 Biomerieux S.A.                        

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Danaher Corporation                             

                8.3 Becton, Dickinson and Company                       

                8.4 Cepheid (U.S.)                          

                8.5 Abbott Laboratories, Inc.                      

                8.6 Alere, Inc.                   

                8.7 Bio-Rad Laboratories Inc                       

                8.8 F. Hoffman-LA Roche Ltd.                    

                8.9 Hologic Inc                  

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of by Microbiology Application, by by Clinical Application along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market.                                                                                                                          
  1. Middle East & Africa Microbiology Testing/Clinical Testing Market By Product, From 2018-2023 ( USD Billion )
  2. Middle East & Africa Instruments Market By Region, From 2018-2023 ( USD Billion )
  3. Middle East & Africa Reagents Market By Region, From 2018-2023 ( USD Billion )
  4. Middle East & Africa Microbiology Testing/Clinical Testing Market By Application, From 2018-2023 ( USD Billion )
  5. Middle East & Africa Pharmaceutical Market By Region, From 2018-2023 ( USD Billion )
  6. Middle East & Africa Clinical Market By Region, From 2018-2023 ( USD Billion )
  7. Middle East & Africa Food Testing Market By Region, From 2018-2023 ( USD Billion )
  8. Middle East & Africa Energy Market By Region, From 2018-2023 ( USD Billion )
  9. Middle East & Africa Chemical and Material Manufacturing Market By Region, From 2018-2023 ( USD Billion )
  10. Middle East & Africa Environmental Market By Region, From 2018-2023 ( USD Billion )
  11. Middle East & Africa Microbiology Testing/Clinical Testing Market By Disease Area, From 2018-2023 ( USD Billion )
  12. Middle East & Africa Respiratory Diseases Market By Region, From 2018-2023 ( USD Billion )
  13. Middle East & Africa Bloodstream Infections Market By Region, From 2018-2023 ( USD Billion )
  14. Middle East & Africa Gastrointestinal Diseases Market By Region, From 2018-2023 ( USD Billion )
  15. Middle East & Africa STD Market By Region, From 2018-2023 ( USD Billion )
  16. Middle East & Africa UTI Market By Region, From 2018-2023 ( USD Billion )
  17. Middle East & Africa Periodontal Diseases Market By Region, From 2018-2023 ( USD Billion )
  18. Middle East & Africa Others Market By Region, From 2018-2023 ( USD Billion )
  19. Middle East Microbiology Testing/Clinical Testing Market By Product, From 2018-2023 ( USD Billion )
  20. Middle East Microbiology Testing/Clinical Testing Market By Application, From 2018-2023 ( USD Billion )
  21. Middle East Microbiology Testing/Clinical Testing Market By Disease Area, From 2018-2023 ( USD Billion )
  22. Africa Microbiology Testing/Clinical Testing Market By Product, From 2018-2023 ( USD Billion )
  23. Africa Microbiology Testing/Clinical Testing Market By Application, From 2018-2023 ( USD Billion )
  24. Africa Microbiology Testing/Clinical Testing Market By Disease Area, From 2018-2023 ( USD Billion )

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients